Next Generation Sequencing-EMEA Market Status and Trend Report 2013-2023
Report Summary
Next Generation Sequencing-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Next Generation Sequencing industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Next Generation Sequencing 2013-2017, and development forecast 2018-2023
Main market players of Next Generation Sequencing in EMEA, with company and product introduction, position in the Next Generation Sequencing market
Market status and development trend of Next Generation Sequencing by types and applications
Cost and profit status of Next Generation Sequencing, and marketing status
Market growth drivers and challenges
The report segments the EMEA Next Generation Sequencing market as:
EMEA Next Generation Sequencing Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Next Generation Sequencing Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
454-Sequencing
Illumina Sequencing
Others
EMEA Next Generation Sequencing Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Oncology
Hereditary Disease Detection
Life Science
EMEA Next Generation Sequencing Market: Players Segment Analysis (Company and Product introduction, Next Generation Sequencing Sales Volume, Revenue, Price and Gross Margin):
Thermo Fisher Scientific
Illumina
Roche Sequencing
Pacific Biosciences
BGI
Novo gene
Biomarker
Roche
Daan Gene
Berry Genomics
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Next Generation Sequencing-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Next Generation Sequencing industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Next Generation Sequencing 2013-2017, and development forecast 2018-2023
Main market players of Next Generation Sequencing in EMEA, with company and product introduction, position in the Next Generation Sequencing market
Market status and development trend of Next Generation Sequencing by types and applications
Cost and profit status of Next Generation Sequencing, and marketing status
Market growth drivers and challenges
The report segments the EMEA Next Generation Sequencing market as:
EMEA Next Generation Sequencing Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Next Generation Sequencing Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
454-Sequencing
Illumina Sequencing
Others
EMEA Next Generation Sequencing Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Oncology
Hereditary Disease Detection
Life Science
EMEA Next Generation Sequencing Market: Players Segment Analysis (Company and Product introduction, Next Generation Sequencing Sales Volume, Revenue, Price and Gross Margin):
Thermo Fisher Scientific
Illumina
Roche Sequencing
Pacific Biosciences
BGI
Novo gene
Biomarker
Roche
Daan Gene
Berry Genomics
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF NEXT GENERATION SEQUENCING
1.1 Definition of Next Generation Sequencing in This Report
1.2 Commercial Types of Next Generation Sequencing
1.2.1 454-Sequencing
1.2.2 Illumina Sequencing
1.2.3 Others
1.3 Downstream Application of Next Generation Sequencing
1.3.1 Oncology
1.3.2 Hereditary Disease Detection
1.3.3 Life Science
1.4 Development History of Next Generation Sequencing
1.5 Market Status and Trend of Next Generation Sequencing 2013-2023
1.5.1 Asia Pacific Next Generation Sequencing Market Status and Trend 2013-2023
1.5.2 Regional Next Generation Sequencing Market Status and Trend 2013-2023
CHAPTER 2 ASIA PACIFIC MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Next Generation Sequencing in Asia Pacific 2013-2017
2.2 Consumption Market of Next Generation Sequencing in Asia Pacific by Regions
2.2.1 Consumption Volume of Next Generation Sequencing in Asia Pacific by Regions
2.2.2 Revenue of Next Generation Sequencing in Asia Pacific by Regions
2.3 Market Analysis of Next Generation Sequencing in Asia Pacific by Regions
2.3.1 Market Analysis of Next Generation Sequencing in China 2013-2017
2.3.2 Market Analysis of Next Generation Sequencing in Japan 2013-2017
2.3.3 Market Analysis of Next Generation Sequencing in Korea 2013-2017
2.3.4 Market Analysis of Next Generation Sequencing in India 2013-2017
2.3.5 Market Analysis of Next Generation Sequencing in Southeast Asia 2013-2017
2.3.6 Market Analysis of Next Generation Sequencing in Australia 2013-2017
2.4 Market Development Forecast of Next Generation Sequencing in Asia Pacific 2018-2023
2.4.1 Market Development Forecast of Next Generation Sequencing in Asia Pacific 2018-2023
2.4.2 Market Development Forecast of Next Generation Sequencing by Regions 2018-2023
CHAPTER 3 ASIA PACIFIC MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Asia Pacific Market Status by Types
3.1.1 Consumption Volume of Next Generation Sequencing in Asia Pacific by Types
3.1.2 Revenue of Next Generation Sequencing in Asia Pacific by Types
3.2 Asia Pacific Market Status by Types in Major Countries
3.2.1 Market Status by Types in China
3.2.2 Market Status by Types in Japan
3.2.3 Market Status by Types in Korea
3.2.4 Market Status by Types in India
3.2.5 Market Status by Types in Southeast Asia
3.2.6 Market Status by Types in Australia
3.3 Market Forecast of Next Generation Sequencing in Asia Pacific by Types
CHAPTER 4 ASIA PACIFIC MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Next Generation Sequencing in Asia Pacific by Downstream Industry
4.2 Demand Volume of Next Generation Sequencing by Downstream Industry in Major Countries
4.2.1 Demand Volume of Next Generation Sequencing by Downstream Industry in China
4.2.2 Demand Volume of Next Generation Sequencing by Downstream Industry in Japan
4.2.3 Demand Volume of Next Generation Sequencing by Downstream Industry in Korea
4.2.4 Demand Volume of Next Generation Sequencing by Downstream Industry in India
4.2.5 Demand Volume of Next Generation Sequencing by Downstream Industry in Southeast Asia
4.2.6 Demand Volume of Next Generation Sequencing by Downstream Industry in Australia
4.3 Market Forecast of Next Generation Sequencing in Asia Pacific by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF NEXT GENERATION SEQUENCING
5.1 Asia Pacific Economy Situation and Trend Overview
5.2 Next Generation Sequencing Downstream Industry Situation and Trend Overview
CHAPTER 6 NEXT GENERATION SEQUENCING MARKET COMPETITION STATUS BY MAJOR PLAYERS IN ASIA PACIFIC
6.1 Sales Volume of Next Generation Sequencing in Asia Pacific by Major Players
6.2 Revenue of Next Generation Sequencing in Asia Pacific by Major Players
6.3 Basic Information of Next Generation Sequencing by Major Players
6.3.1 Headquarters Location and Established Time of Next Generation Sequencing Major Players
6.3.2 Employees and Revenue Level of Next Generation Sequencing Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 NEXT GENERATION SEQUENCING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Thermo Fisher Scientific
7.1.1 Company profile
7.1.2 Representative Next Generation Sequencing Product
7.1.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific
7.2 Illumina
7.2.1 Company profile
7.2.2 Representative Next Generation Sequencing Product
7.2.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Illumina
7.3 Roche Sequencing
7.3.1 Company profile
7.3.2 Representative Next Generation Sequencing Product
7.3.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Roche Sequencing
7.4 Pacific Biosciences
7.4.1 Company profile
7.4.2 Representative Next Generation Sequencing Product
7.4.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Pacific Biosciences
7.5 BGI
7.5.1 Company profile
7.5.2 Representative Next Generation Sequencing Product
7.5.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of BGI
7.6 Novo gene
7.6.1 Company profile
7.6.2 Representative Next Generation Sequencing Product
7.6.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Novo gene
7.7 Biomarker
7.7.1 Company profile
7.7.2 Representative Next Generation Sequencing Product
7.7.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Biomarker
7.8 Roche
7.8.1 Company profile
7.8.2 Representative Next Generation Sequencing Product
7.8.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Roche
7.9 Daan Gene
7.9.1 Company profile
7.9.2 Representative Next Generation Sequencing Product
7.9.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Daan Gene
7.10 Berry Genomics
7.10.1 Company profile
7.10.2 Representative Next Generation Sequencing Product
7.10.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Berry Genomics
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NEXT GENERATION SEQUENCING
8.1 Industry Chain of Next Generation Sequencing
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF NEXT GENERATION SEQUENCING
9.1 Cost Structure Analysis of Next Generation Sequencing
9.2 Raw Materials Cost Analysis of Next Generation Sequencing
9.3 Labor Cost Analysis of Next Generation Sequencing
9.4 Manufacturing Expenses Analysis of Next Generation Sequencing
CHAPTER 10 MARKETING STATUS ANALYSIS OF NEXT GENERATION SEQUENCING
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Next Generation Sequencing in This Report
1.2 Commercial Types of Next Generation Sequencing
1.2.1 454-Sequencing
1.2.2 Illumina Sequencing
1.2.3 Others
1.3 Downstream Application of Next Generation Sequencing
1.3.1 Oncology
1.3.2 Hereditary Disease Detection
1.3.3 Life Science
1.4 Development History of Next Generation Sequencing
1.5 Market Status and Trend of Next Generation Sequencing 2013-2023
1.5.1 Asia Pacific Next Generation Sequencing Market Status and Trend 2013-2023
1.5.2 Regional Next Generation Sequencing Market Status and Trend 2013-2023
CHAPTER 2 ASIA PACIFIC MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Next Generation Sequencing in Asia Pacific 2013-2017
2.2 Consumption Market of Next Generation Sequencing in Asia Pacific by Regions
2.2.1 Consumption Volume of Next Generation Sequencing in Asia Pacific by Regions
2.2.2 Revenue of Next Generation Sequencing in Asia Pacific by Regions
2.3 Market Analysis of Next Generation Sequencing in Asia Pacific by Regions
2.3.1 Market Analysis of Next Generation Sequencing in China 2013-2017
2.3.2 Market Analysis of Next Generation Sequencing in Japan 2013-2017
2.3.3 Market Analysis of Next Generation Sequencing in Korea 2013-2017
2.3.4 Market Analysis of Next Generation Sequencing in India 2013-2017
2.3.5 Market Analysis of Next Generation Sequencing in Southeast Asia 2013-2017
2.3.6 Market Analysis of Next Generation Sequencing in Australia 2013-2017
2.4 Market Development Forecast of Next Generation Sequencing in Asia Pacific 2018-2023
2.4.1 Market Development Forecast of Next Generation Sequencing in Asia Pacific 2018-2023
2.4.2 Market Development Forecast of Next Generation Sequencing by Regions 2018-2023
CHAPTER 3 ASIA PACIFIC MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Asia Pacific Market Status by Types
3.1.1 Consumption Volume of Next Generation Sequencing in Asia Pacific by Types
3.1.2 Revenue of Next Generation Sequencing in Asia Pacific by Types
3.2 Asia Pacific Market Status by Types in Major Countries
3.2.1 Market Status by Types in China
3.2.2 Market Status by Types in Japan
3.2.3 Market Status by Types in Korea
3.2.4 Market Status by Types in India
3.2.5 Market Status by Types in Southeast Asia
3.2.6 Market Status by Types in Australia
3.3 Market Forecast of Next Generation Sequencing in Asia Pacific by Types
CHAPTER 4 ASIA PACIFIC MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Next Generation Sequencing in Asia Pacific by Downstream Industry
4.2 Demand Volume of Next Generation Sequencing by Downstream Industry in Major Countries
4.2.1 Demand Volume of Next Generation Sequencing by Downstream Industry in China
4.2.2 Demand Volume of Next Generation Sequencing by Downstream Industry in Japan
4.2.3 Demand Volume of Next Generation Sequencing by Downstream Industry in Korea
4.2.4 Demand Volume of Next Generation Sequencing by Downstream Industry in India
4.2.5 Demand Volume of Next Generation Sequencing by Downstream Industry in Southeast Asia
4.2.6 Demand Volume of Next Generation Sequencing by Downstream Industry in Australia
4.3 Market Forecast of Next Generation Sequencing in Asia Pacific by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF NEXT GENERATION SEQUENCING
5.1 Asia Pacific Economy Situation and Trend Overview
5.2 Next Generation Sequencing Downstream Industry Situation and Trend Overview
CHAPTER 6 NEXT GENERATION SEQUENCING MARKET COMPETITION STATUS BY MAJOR PLAYERS IN ASIA PACIFIC
6.1 Sales Volume of Next Generation Sequencing in Asia Pacific by Major Players
6.2 Revenue of Next Generation Sequencing in Asia Pacific by Major Players
6.3 Basic Information of Next Generation Sequencing by Major Players
6.3.1 Headquarters Location and Established Time of Next Generation Sequencing Major Players
6.3.2 Employees and Revenue Level of Next Generation Sequencing Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 NEXT GENERATION SEQUENCING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Thermo Fisher Scientific
7.1.1 Company profile
7.1.2 Representative Next Generation Sequencing Product
7.1.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific
7.2 Illumina
7.2.1 Company profile
7.2.2 Representative Next Generation Sequencing Product
7.2.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Illumina
7.3 Roche Sequencing
7.3.1 Company profile
7.3.2 Representative Next Generation Sequencing Product
7.3.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Roche Sequencing
7.4 Pacific Biosciences
7.4.1 Company profile
7.4.2 Representative Next Generation Sequencing Product
7.4.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Pacific Biosciences
7.5 BGI
7.5.1 Company profile
7.5.2 Representative Next Generation Sequencing Product
7.5.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of BGI
7.6 Novo gene
7.6.1 Company profile
7.6.2 Representative Next Generation Sequencing Product
7.6.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Novo gene
7.7 Biomarker
7.7.1 Company profile
7.7.2 Representative Next Generation Sequencing Product
7.7.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Biomarker
7.8 Roche
7.8.1 Company profile
7.8.2 Representative Next Generation Sequencing Product
7.8.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Roche
7.9 Daan Gene
7.9.1 Company profile
7.9.2 Representative Next Generation Sequencing Product
7.9.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Daan Gene
7.10 Berry Genomics
7.10.1 Company profile
7.10.2 Representative Next Generation Sequencing Product
7.10.3 Next Generation Sequencing Sales, Revenue, Price and Gross Margin of Berry Genomics
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NEXT GENERATION SEQUENCING
8.1 Industry Chain of Next Generation Sequencing
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF NEXT GENERATION SEQUENCING
9.1 Cost Structure Analysis of Next Generation Sequencing
9.2 Raw Materials Cost Analysis of Next Generation Sequencing
9.3 Labor Cost Analysis of Next Generation Sequencing
9.4 Manufacturing Expenses Analysis of Next Generation Sequencing
CHAPTER 10 MARKETING STATUS ANALYSIS OF NEXT GENERATION SEQUENCING
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference